First-in-human study of SAR445611 in healthy adult participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502923-23-00

Acronym

SAD17732-MAD17733

Enrollment

234

Registered

2023-06-06

Start date

2023-06-12

Completion date

2024-08-07

Last updated

2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune system diseases

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026